The Effects of Sevoflurane on Systemic and Pulmonary Inflammatory Responses After Cardiopulmonary Bypass

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 23, Issue 5, 2009, Pages 639-645

  Cho, Eun Jung ^a   Yoon, Jong Hyun ^b   Hong, Sung Jin ^b   Lee, Sun Hee ^b   Sim, Sung Bo ^b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

cardiopulmonary bypass; cytokine; inflammatory response; sevoflurane

Indexed keywords

CYTOKINE; INTERLEUKIN 8; SEVOFLURANE; SUFENTANIL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART PROTECTION; HUMAN; KIDNEY FAILURE; LEUKOCYTE COUNT; MALE; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANESTHETICS, INHALATION; CARDIOPULMONARY BYPASS; FEMALE; HUMANS; MALE; METHYL ETHERS; MIDDLE AGED; PNEUMONIA; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES;

EID: 70349303782     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2009.01.025     Document Type: Article

References (32)

1. Larmann J., and Theilmeier G. Inflammatory response to cardiac surgery: cardiopulmonary bypass versus non-cardiopulmonary bypass surgery. Best Prac Res Clin Anaesth 18 (2004) 425-438
2. Cameron D. Initiation of white cell activation during cardiopulmonary bypass: Cytokines and receptors. J Cardiovasc Pharmacol 27 suppl 1 (1996) S1-S5
3. Massaudy P., Zahler S., Becker B.F., et al. Significant leukocyte and platelet retention during pulmonary passage after declamping of the aorta in CABG patients. Eur J Med Res 4 (1999) 178-182
4. Massaudy P., Zahler S., Becker B.F., et al. Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass. Chest 119 (2001) 31-36
5. Shafique T., Johnson R.G., Dai H.B., et al. Altered pulmonary microvascular reactivity after total cardiopulmonary bypass. J Thorac Cardiovasc Surg 106 (1993) 479-486
6. Ng C.S.H., Wan S., Arifi A.A., et al. Inflammatory response to pulmonary ischemia-reperfusion injury. Surg Today 36 (2006) 205-214
7. El-Azab S.R., Rosseel P.M.J., DeLange J.J., et al. Effect of sevoflurane on the ex vivo secretion of TNF-α during and after coronary artery bypass surgery. Eur J Anaesth 20 (2003) 380-384
8. Nader N.D., Karamanoukian H.L., Reedy R.L., et al. Inclusion of sevoflurane in cardioplegia reduces neutrophil activity during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 20 (2006) 57-62
9. El-Azab S.R., Roseel P.M.J., DeLange J.J., et al. Effect of VIMA with sevoflurane versus TIVA with propofol or midazolam-sufentanil on the cytokine response during CABG surgery. Eur J Anaesth 19 (2002) 276-282
10. Brix-Christensen V., Tonnesen E., Sorensen I.J., et al. Effects of anaesthesia based on high-versus-low dose opioids on cytokine and acute-phase protein responses in patients undergoing cardiac surgery. Acta Anaesth Scand 42 (1998) 63-70
11. Wan S., DeSmert J.M., Barvais L., et al. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 112 (1996) 806-811
12. Liebold A., Keyl C., and Birnbaum D.E. The heart produces but the lungs consume proinflammatory cytokines following cardiopulmonary bypass. Eur J Cardiovasc Surg 15 (1999) 340-345
13. Nader N.D., Li C.M., Khadra W.Z., et al. Anesthetic myocardial protection with sevoflurane. J Cardiothorac Vasc Anesth 18 (2004) 269-274
14. Guarracino F., Landoni G., Tritapepe L., et al. Myocardial damages prevented by volatile anesthetics: A multicenter randomized controlled study. J Cardiothorac Vasc Anesth 20 (2006) 477-483
15. Landoni G., Biondi-Zoccai G.L., Zangrillo A., et al. Desflurane and sevoflurane in cardiac surgery: A meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 21 (2007) 502-511
16. Tritapepe L., Landoni G., Guarracino F., et al. Cardiac protection by volatile anesthetics: A multicentre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Eur J Anaesth 24 (2007) 323-331
17. Suleiman M.S., Zacharowski K., and Angelini G.D. Inflammatory response and cardioprotection during open-heart surgery: The importance of anaesthetics. Br J Pharmacol 153 (2008) 21-33
18. Rashid M.A., and William-Olsson G. Are leukocytosis and lipid peroxidation involved in ischemic or reperfusion injury in cardiac surgery?. Thorac Cardiovasc Surg 39 (1991) 193-195
19. Hall I., Smith M.F., and Rocker G. The systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic, and pharmacological consideration. Anesth Analg 85 (1997) 766-782
20. Abdelhadi R.H., Gurm H.S., VanWagoner D.R., et al. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. Am J Cardiol 93 (2004) 1176-1178
21. Ascione R., Lloyd C.T., Underwood M.J., et al. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 69 (2000) 1198-1204
22. Zahler S., Massaudy P., Hartl H., et al. Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass. Cardiovasc Res 41 (1999) 722-730
23. Alcaraz A.J., Manzano L., Sancho L., et al. Different proinflammatory cytokine serum pattern in neonate patients undergoing open heart surgery. Relevance of IL-8. J Clin Immunol 25 (2005) 238-245
24. Kunkel S.L., Standiford T., Kasahara K., et al. Interleukin-8(IL-8): The major neutrophil chemotactic factor in the lung. Exp Lung Res 17 (1991) 17-23
25. Takala R.S.K., Soukka H.R., Salo M.S., et al. Pulmonary inflammatory mediators after sevoflurane and thiopentone anaesthesia in pigs. Acta Anaesthesiolo Scand 48 (2004) 40-45
26. Kotani N., Takahashi S., Sessler D.I., et al. Volatile anesthetics augment expression of proinflammatory cytokines in rat alveolar macrophages during mechanical ventilation. Anesthesiology 91 (1999) 187-197
27. Hung C.J., Liu F.Y., Shaiu Y.C., et al. Assessing transient pulmonary injury induced by volatile anesthetics by increased lung uptake of Technetium-99m hexamethylpropylene amine oxime. Lung 181 (2003) 1-7
28. Schilling T., Kozian A., Kretzschmar M., et al. Effects of propofol and desflurane anaesthesia on the alveolar inflammation response to one-lung ventilation. Br J Anaesth 99 (2007) 368-375
29. Giomarelli P., Scoletta S., Borelli E., et al. Myocardial and lung injury after cardiopulmonary bypass: Role of interleukin (IL)-10. Ann Thorac Surg 76 (2003) 117-123
30. Celik J.B., Gormus N., Okesli S., et al. Methylprednisolone prevents inflammatory reaction occurring during cardiopulmonary bypass: effects on TNF-α, IL-6, IL-8, IL-10. Perfusion 19 (2004) 185-191
31. Conzen P.F., Fischer S., Detter C., et al. Sevoflurane provide greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology 99 (2003) 826-833
32. Bein B., Renner J., Caliebe D., et al. Sevoflurane but not propofol preserves myocardial function during minimally invasive direct coronary artery bypass surgery. Anesth Analg 100 (2005) 610-616